Business Description
The Hydration Pharmaceuticals Co Ltd
ISIN : AU0000187957
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.47 | |||||
Equity-to-Asset | -0.05 | |||||
Debt-to-Equity | -10.87 | |||||
Debt-to-EBITDA | -0.52 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -10.33 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.24 | |||||
9-Day RSI | 38.11 | |||||
14-Day RSI | 40.98 | |||||
6-1 Month Momentum % | -60 | |||||
12-1 Month Momentum % | -80.96 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.13 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 0.59 | |||||
Days Inventory | 200.74 | |||||
Days Sales Outstanding | 51.8 | |||||
Days Payable | 94.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 28.61 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 53.71 | |||||
Operating Margin % | -77.11 | |||||
Net Margin % | -80.7 | |||||
FCF Margin % | -57.06 | |||||
ROE % | -626.58 | |||||
ROA % | -110.94 | |||||
ROIC % | -341.12 | |||||
ROC (Joel Greenblatt) % | -351.56 | |||||
ROCE % | -160.3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.17 | |||||
EV-to-EBIT | -0.63 | |||||
EV-to-EBITDA | -0.63 | |||||
EV-to-Revenue | 0.47 | |||||
EV-to-FCF | -0.82 | |||||
Earnings Yield (Greenblatt) % | -157.88 | |||||
FCF Yield % | -215.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
The Hydration Pharmaceuticals Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 14.987 | ||
EPS (TTM) (A$) | -0.06 | ||
Beta | 0 | ||
Volatility % | 53.62 | ||
14-Day RSI | 40.98 | ||
14-Day ATR (A$) | 0.000259 | ||
20-Day SMA (A$) | 0.0135 | ||
12-1 Month Momentum % | -80.96 | ||
52-Week Range (A$) | 0.012 - 0.060103 | ||
Shares Outstanding (Mil) | 304.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
The Hydration Pharmaceuticals Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
The Hydration Pharmaceuticals Co Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
The Hydration Pharmaceuticals Co Ltd Frequently Asked Questions
What is The Hydration Pharmaceuticals Co Ltd(ASX:HPC)'s stock price today?
When is next earnings date of The Hydration Pharmaceuticals Co Ltd(ASX:HPC)?
Does The Hydration Pharmaceuticals Co Ltd(ASX:HPC) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |